# IMDELLTRA
> **BLA761344** · Biologics License Application · Sponsor: AMGEN INC · Approved 2024-05-16
## Drug
- **FDA Application Number:** BLA761344
- **Application type:** Biologics License Application
- **Brand name:** IMDELLTRA
- **Generic name:** TARLATAMAB-DLLE
- **Active ingredients:** TARLATAMAB-DLLE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **Manufacturer:** Amgen, Inc
- **First approval:** 2024-05-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761344)
---
*MORVS · CC0 1.0*